https://www.marketscreener.com/quote/stock/EISAI-CO-LTD-6492461/news/Why-a-new-Alzheimer-s-drug-is-having-a-slow-US-debut-42896770/
The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away. Two big factors behind the slow debut, experts say,... | February 4, 2023
Create an account or login to join the discussion